PM Modi reviews preparedness of COVID-19 vaccine delivery, distribution, administration

NewsBharati    21-Nov-2020
Total Views |
New Delhi, November 21: Amid a sudden spike in the new covid case in the country, Prime Minister Narendra Modi on Friday held a meeting to review the preparedness of Covid-19 vaccine delivery, distribution, and administration.
 
Covid_1  H x W:
 
 
Modi also discussed important issues related to the progress of vaccine development, regulatory approvals, and procurement. They also reviewed various issues like prioritisation of population groups, reaching out to HCWs, cold-chain infrastructure augmentation, adding vaccinators, and tech platform for vaccine roll-out.
 
Prime Minister appreciated the efforts of innovators, scientists, academicians, and pharma-companies in their efforts to develop vaccines and directed that every effort should be made to facilitate the research, development, and manufacturing of the vaccine.
 
 
 
This comes two days after the Centre on November 18 had announced its decision on the COVID-19 vaccine for India and stated when it will be available for the people.
 
According to the data, five vaccines are in advanced stages of development in India, out of which four are in Phase II or III and one is in Phase-I or II.
 
The vaccination supply chain is being enhanced and non-vaccine supplies are being escalated. Medical and nursing students and faculty will be involved in the training and implementation of the vaccination program. Every step is being steadily put in place to ensure that vaccines reach every location and person according to the prioritisation principles.
 
Reviewing the situation PM directed to work in collaboration with all reputed national and international institutions and regulators to ensure the rigor and highest global standards in Indian research and manufacturing.
 
National Expert Group on Vaccine Administration for Covid-19 in consultation with State Governments and all relevant stakeholders has accelerated the implementation of vaccination of priority groups in the first phase.
 
Modi also directed that a time-bound plan be laid out for speedy regulatory clearances and timely procurement for early rollout of the vaccination drive.
 
In the meeting, he also appreciated comprehensive efforts at vaccine development. He also emphasised that given the persisting pandemic scenario there is no place for any relaxation in preventive measures such as wearing masks, keeping distance, and ensuring hygiene.
The meeting was attended by Principal Secretary to Prime Minister, Cabinet Secretary, Member (Health) NITI Aayog, Principal Scientific Advisor, Secretary Health, DG ICMR, officers of PMO, and Secretaries of related Departments of Government of India.